Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3115_Библиотеки_им_академика_М_И_Перельмана
.pdf
Yaffe M. J., Mainprize J. G. Risk of radiation-induced breast cancer from
mammographic screening // Radiology. 2011. January. Vol. 258. № 1. P. 98–105.
WHO position paper on mammography screening. World Health Organization, 2014.
Schroder F. H., Hugosson J., Roobol M. J. et al. Screening and prostate-cancer
mortality in a randomized european study // The New England Journal of Medicine. 2009.
Vol. 360. № 13. P. 1320–1328.
Draisma G., Boer R., Otto S. J. et al. Lead times and overdetection due to prostate-
specific antigen screening: estimates from the European Randomized Study of Screening for
Prostate Cancer // Journal of the National Cancer Institute. 2003. June 18. Vol. 95. № 12. P.
868–878.
Gillies D. Hempelian and Kuhnian approaches in the philosophy of medicine: the
Semmelweis Case // Studies in history and philosophy of biological and biomedical
sciences. 2005. March. Vol. 36. № 1. P. 159–181.
Noakes T. D., Borresen J., Hew-Butler T., Lambert M. I., Jordaan E. Semmelweis and
the aetiology of puerperal sepsis 160 years on: an historical review // Epidemiology and
infection. 2008. January. Vol. 136. № 1. P. 1–9.
Dunn P. M. Ignac Semmelweis (1818–1865) of Budapest and the prevention of
puerperal fever // Archives of disease in childhood. Fetal and neonatal edition. 2005. Vol.
90. № 4, F345–348.
Semmelweis I. The etiology, concept, and prophylaxis of childbed fever. Madison and
London: The University of Wisconsin Press, 1983.
Best M., Neuhauser D. Ignaz Semmelweis and the birth of infection control // Quality
& safety in health care. 2004. June. Vol. 13. № 3. P. 233–234.
Bridson E. Y. Iatrogenic epidemics of puerperal fever in the 18th and 19th centuries //
British journal of biomedical science. 1996. June. Vol. 53. № 2. P. 134–139.
Alper B. S., Hand J. A., Elliott S. G., Kinkade S., Hauan M. J., Onion D. K. et al. How
much effort is needed to keep up with the literature relevant for primary care? // Journal of
the Medical Library Association. 2004. October. Vol. 92. № 4. P. 429–437.
Neuman J., Korenstein D., Ross J. S., Keyhani S. Prevalence of financial conflicts of
interest among panel members producing clinical practice guidelines in Canada and
United States: cross sectional study // BMJ. 2011. Vol. 343. № 7827, d5621.
Khan R., Scaffidi M. A., Rumman A., Grindal A. W., Plener I. S., Grover S. C.
Prevalence of financial conflicts of interest among authors of clinical guidelines related to
high-revenue medications // JAMA Internal Medicine. 2018. Vol. 178. № 12. P. 1712–1715.
Combs T. R., Scott J., Jorski A., Heavener T., Vassar M. Evaluation of industry
relationships among authors of clinical practice guidelines in gastroenterology // JAMA
Internal Medicine. 2018. Vol. 178. № 12. P. 1711–1712.
McAlister F. A., Van Diepen S., Padwal R. S., Johnson J. A., Majumdar S. R. How
evidence-based are the recommendations in evidence-based guidelines? // Plos Medicine.
2007. Vol. 4. № 8, e250.
Marciano N. J., Merlin T. L., Bessen T., Street J. M. To what extent are current
guidelines for cutaneous melanoma follow up based on scientific evidence? // International
journal of clinical practice. 2014. June. Vol. 68. № 6. P. 761–770.
De Blois J., Fagerland M. W., Grundtvig M., Semb A. G., Gullestad L.et al. ESC
guidelines adherence is associated with improved survival in patients from the Norwegian
https://t.me/medicina_free
Heart Failure Registry // European Heart Journal. Cardiovascular Pharmacotherapy. 2015.
January 1. Vol. 1. № 1. P. 31–36.
Tsugawa Y., Newhouse J. P., MacArthur J. D., Zaslavsky A. M. et al. Physician age
and outcomes in elderly patients in hospital in the US: observational study // BMJ. 2017.
Vol. 357. № 8106, j1797.
Nooh A., Baghdadi S., Raouf S. Induction of labour: how close to the evidence-based
guidelines are we? // Journal of Obstetrics and Gynaecology. 2005. Vol. 25. № 5. P. 451–
454.
Kondov K.; Sharpe P.; Mousa H. Are we following the guidelines – a retrospective
analysis of compliance with evidence based protocols in cases admitted to Intensive Care
Unit (ICU) from Labour Ward (LW): 1AP2–2 // European Journal of Anaesthesiology.
2012. June. Vol. 29. P. 9.
Holmes J. S., Shevrin M., Goldman, B., Share D. Translating research into practice:
are physicians following evidence-based guidelines in the treatment of hypertension? //
Medical Care Research and Review. 2004. Vol. 61. № 4. P. 453–473.
Gabbay J., Le May A. Evidence based guidelines or collectively constructed
“mindlines”? Ethnographic study of knowledge management in primary care // BMJ. 2004.
October 30. Vol. 329. № 7473. P. 1013–1018.
André M., Borgquist L., Foldevi M., Mölstad S. Asking for ‘rules of thumb’: a way to
discover tacit knowledge in general practice // Family practice. 2002. December. Vol. 19.
№ 6. P. 617–622.
André M., Borgquist L., Mölstad S. Use of rules of thumb in the consultation in
general practice – an act of balance between the individual and the general perspective //
Family practice. 2003. October. Vol. 20. № 5. P. 514–519.
Зайцева Е. А. Клинический выбор врачей в крупном российском городе: опыт
качественного анализа // Медицинская антропология и биоэтика. 2018. Т. 1. № 15.
Hajjaj F. M., Salek M. S., Basra M. K. A., Finlay A. Y. Non-clinical influences on
clinical decision-making: a major challenge to evidence-based practice // Journal of the
Royal Society of Medicine. 2010. May 1. Vol. 103. № 5. P. 178–187.
Bernheim S. M., Ross J. S., Krumholz H. M., Bradley E. H. Influence of patients’
socioeconomic status on clinical management decisions: a qualitative study // Annals of
family medicine. 2008. January. Vol. 6. № 1. P. 53–59.
Arie S. Ending the French love affair with drugs // BMJ. 2012. Vol. 345. № 7879,
e6996.
Prasad V., Vandross A., Toomey C., Cheung M., Rho J., Quinn S. et al. A decade of
reversal: an analysis of 146 contradicted medical practices // Mayo Clinic proceedings.
2013. August. Vol. 88. № 8. P. 790–798.
Garrow J. S. How much of orthodox medicine is evidence based? // BMJ. 2007. Vol.
335. № 7627. P. 951.
Меркулова Л. Н. Колобухина Л. В., Кистенева Л. Б. и др. Терапевтическая
эффективность Кагоцела при лечении больных не осложненным гриппом и гриппом,
осложненным ангиной // Клиническая фармакология и терапия. 2002. Т. 11. № 6. С.
21–23.
Фазылов В. Х., Ситников И. Г., Силина Е. В., Шевченко С. Б., Можина Л. Н. и др.
Лечение больных ОРВИ и гриппом в повседневной клинической практике (результаты
https://t.me/medicina_free
многоцентрового международного наблюдательного исследования FLU-EE) //
Терапевтический архив. 2016. Т. 88. № 11. С. 68–75.
Алиферова В. М., Дадашева М. Н., Доронин Б. М., Коваленко А. В. и др.
Клиническая эффективность и фармакоэкономические характеристики
нейропротекции низкими дозами кортексина в терапии острого ишемического
инсульта // Журнал неврологии и психиатрии им. С. С. Корсакова. 2014. Т. 114. № 4.
С. 41–46.
Howes N., Chagla L., Thorpe M., McCulloch P. Surgical practice is evidence based //
The British journal of surgery. 1997. September. Vol. 84. № 9. P. 1220–1223.
Kehlet H., Wilmore D. W. Multimodal strategies to improve surgical outcome // The
American Journal of Surgery. 2002. Vol. 183. P. 630–641.
Kehlet H., Dahl J. B. Anaesthesia, surgery, and challenges in postoperative recovery //
Lancet. 2003. Vol. 362. P. 1921–1928.
Wartolowska K., Judge A., Hopewell S., Collins G. S., Dean B. J. F. et al. Use of
placebo controls in the evaluation of surgery: systematic review // BMJ. 2014. Vol. 348. №
7960, g3253.
Solomon M. J., Laxamana A., Devore L., McLeod R. S. Randomized controlled trials
in surgery // Surgery. 1994. June 1. Vol. 115. № 6. P. 707–712.
Cobb L. A., Thomas G. I., Dillard D. H., Merendino K. A., Bruce R. A. An evaluation
of internal-mammary-artery ligation by a double-blind technic // The New England Journal
of Medicine. 1959. May 28. Vol. 260. № 22. P. 1115–1118.
Siemieniuk R. A. C., Harris I. A., Agoritsas T., Poolman R. W. et al. Arthroscopic
surgery for degenerative knee arthritis and meniscal tears: a clinical practice guideline //
BMJ. 2017. Vol. 357. № 8105, j1982.
Freed C. R., Greene P. E., Breeze R. E., Tsai W. Y., DuMouchel W., Kao R. et al.
Transplantation of embryonic dopamine neurons for severe Parkinson’s disease // The New
England journal of medicine. 2001. March 8. Vol. 344. № 10. P. 710–719.
Tsugawa Y., Jena A. B., Newhouse R. L., Orav E. J., Blumenthal D. M. et al. Age and
sex of surgeons and mortality of older surgical patients: observational study // BMJ. 2018.
Vol. 361. № 8150, k1343.
Papanikolaou P. N., Churchill R., Wahlbeck K., Ioannidis J. P. A. Safety reporting in
randomized trials of mental health interventions // American Journal of Psychiatry. 2004.
Vol. 161. P. 1692–1697.
Smith M. L., Glass G. V. Meta-analysis of psychotherapy outcome studies // The
American psychologist. 1977. September. Vol. 32. № 9. P. 752–760.
Landman J. T., Dawes R. M. Psychotherapy outcome: Smith and Glass’ conclusions
stand up under scrutiny // American Psychologist. 1982. Vol. 37. № 5. P. 504–516.
Luborsky L., Singer B., Luborsky L. Comparative studies of psychotherapies: is it true
that “Everyone has won and all must have prizes”? // Archives of General Psychiatry.
1975. Vol. 32. № 8. P. 995–1008.
Strupp H. H., Hadley S. W. Specific vs nonspecific factors in psychotherapy. A
controlled study of outcome // Archives of general psychiatry. 1979. September. Vol. 36. №
10. P. 1125–1136.
Bootzin R. R., Bailey E. T. Understanding placebo, nocebo, and iatrogenic treatment
effects // Journal of clinical psychology. 2005. July. Vol. 61. № 7. P. 871–880.
https://t.me/medicina_free
Butler A. C., Chapman J. E., Forman E. M., Beck A. T. The empirical status of
cognitive-behavioral therapy: A review of meta-analyses // Clinical Psychology Review.
2006. Vol. 26. P. 17–31.
Tolin D. F. Is cognitive-behavioral therapy more effective than other therapies? A
meta-analytic review // Clinical Psychology Review. Vol. 30. № 6. P. 710–720.
Barth J., Munder T., Gerger H., Nüesch E., Trelle S., Znoj H. et al. Comparative
efficacy of seven psychotherapeutic interventions for patients with depression: a network
meta-analysis // PLoS Med. 2013. Vol. 10. № 5, e1001454.
Mayo-Wilson E., Dias S., Mavranezouli I., Kew K. et al. Psychological and
pharmacological interventions for social anxiety disorder in adults: a systematic review
and network meta-analysis // Lancet Psychiatry. 2014. Vol. 1. № 5. P. 368–376.
Marcus D. K., O’Connell D., Norris A. L., Sawaqdeh A. Is the Dodo bird endangered
in the 21st century? A meta-analysis of treatment comparison studies // Clinical Psychology
Review. 2014. November. Vol. 34. № 7. P. 519–530.
Wampold B. E., Flückiger C., Del Re A. C., Yulish N. E., Frost N. D., Pace B. T. et al
In pursuit of truth: A critical examination of meta-analyses of cognitive behavior therapy //
Psychotherapy Research. 2017. Vol. 27. № 1. P. 14–32.
Van Emmerik A. A. P., Kamphuis J. H, Hulsbosch A. M., Emmelkamp P. M. G. Single
session debriefing after psychological trauma: a meta-analysis // Lancet. 2002. September
07. Vol. 360. № 9335. P. 766–771.
Rose S., Brewin C. R., Andrews B., Kirk M. A randomized controlled trial of
individual psychological debriefing for victims of violent crime // Psychological Medicine.
1999. July. Vol. 29. № 4. P. 793–799.
Roberts N. P., Kitchiner N. J., Kenardy J., Bisson J. I. Multiple session early
psychological interventions for the prevention of posttraumatic stress disorder // Cochrane
Database of Systematic Reviews. 2009. № 3. Art. № CD006869. Coulter I. D., Willis E. M.
The rise and rise of complementary and alternative medicine: a sociological perspective //
MJA. 2004. June 7. Vol. 180. P. 587–589.
Sampson W. Antiscience trends in the rise of the “alternative medicine” movement //
Annals of the New York Academy of Sciences. 1996. June 24. Vol. 775. P. 188–197.
Eisenberg D. M., Davis R. B., Ettner S. L. et al. Trends in alternative medicine use in
the United States, 1990–1997 // JAMA. 1998. Vol. 280. № 18. P. 1569–1575.
Murray J., Shepherd S. Alternative or additional medicine? An exploratory study in
general practice // Social science & medicine. 1993. Vol. 37. № 8. P. 983–988.
Homeopathic Medicine & Advertising: An FTC Workshop Comments of the American
Association of Homeopathic Pharmacists. 2015. November 20.
DSM Group: гомеопатические препараты занимают менее 1% рынка лекарств
России // Фармацевтический вестник. 2017. 6 февраля.
Mathie R. T., Frye J., Fisher P. Homeopathic Oscillococcinum® for preventing and
treating influenza and influenza-like illness // Cochrane Database of Systematic Reviews.
2015. № 1. Art. № CD001957.
Pakpoor J. Homeopathy is not an effective treatment for any health condition, report
concludes // 2015. Vol. 350. № 8000, h1478.
Носырев И. Гомеопатия как искусство и выгодное дело // Коммерсантъ Деньги.
07.11.2016. №.44. C. 24.
https://t.me/medicina_free
Kim S., Cha J. M., Lee C. H., Shin H. P., Park J. J., Joo K. R., Lee J. I. et al. Rectal
perforation due to benign stricture caused by rectal burns associated with hot coffee
enemas // Endoscopy. 2012. Vol. 44. Suppl 2. UCTN: E32–3.
Shils M. E., Hermann M. G. Unproved dietary claims in the treatment of patients with
cancer // Bulletin of the New York Academy of Medicine. 1982. April. Vol. 58. № 3. P.
323–340.
Eisele J. W., Reay D. T. Deaths related to coffee enemas // JAMA. 1980. Vol. 244. №
14. P. 1608–1609.
Margolin K. A., Green M. R. Polymicrobial enteric septicemia from coffee enemas //
The Western journal of medicine. 1984. March. Vol. 140. № 3. P. 460.
Bogdanich W. Chinese chemicals flow unchecked onto world drug market // The New
York Times. 2007. October 31.
Yang D. L. Regulatory learning and its discontents in China: promise and tragedy at
the state food and drug administration / Gillespie J., Peerenboom R. (eds.) Pushing Back
Globalization. Routledge, 2009.
Patwardhan B., Warude D., Pushpangadan P., Bhatt N. Ayurveda and traditional
Chinese medicine: a comparative overview // Evidence-based complementary and
alternative medicine. 2005. December. Vol. 2. № 4. P. 465–473.
Deadman P., Al-Khafaji M. Some acupuncture points which treat disorders of blood //
Journal of Chinese Medicine. 1998. January. № 56. P. 5–18.
Rudic J. S., Poropat G., Krstic M. N., Bjelakovic G., Gluud C. Ursodeoxycholic acid
for primary biliary cirrhosis // Cochrane Database of Systematic Reviews. 2012. № 12. Art.
№ CD000551.
Vickers A., Goyal N., Harland R., Rees R. Do certain countries produce only positive
results? A systematic review of controlled trials // Controlled clinical trials. 1998. April.
Vol. 19. № 2. P. 159–166.
Colquhoun D., Novella S. P. Acupuncture is theatrical placebo // Anesthesia and
analgesia. 2013. June. Vol.116. № 6. P. 1360–1363.
Topping A. Chinese use acupuncture anesthetic in heart surgery // The New York
Times. 1971. May 24.
Ernst E., Lee M. S., Choi T. Y. Acupuncture: does it alleviate pain and are there
serious risks? A review of reviews // Pain. 2011. April. Vol. 152. № 4. P. 755–764.
Deare J. C., Zheng Z., Xue C. C. L., Liu J. P., Shang J., Scott S. W., Littlejohn G.
Acupuncture for treating fibromyalgia // Cochrane Database of Systematic Reviews. 2013.
№ 5. Art. № CD007070.
Manheimer E., Cheng K., Linde K., Lao L., Yoo J., Wieland S. et al. Acupuncture for
peripheral joint osteoarthritis // Cochrane Database of Systematic Reviews. 2010. January
20. № 1. Art. № CD001977.
Madsen M. V., Gøtzsche P. C. Acupuncture treatment for pain: systematic review of
randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture
groups // BMJ. 2009. Vol. 338. № 7690, a3115.
Linde K., Allais G., Brinkhaus B., Manheimer E., Vickers A., White A. R.
Acupuncture for migraine prophylaxis // Cochrane Database of Systematic Reviews. 2009.
№ 1. Art. № CD001218.
https://t.me/medicina_free
Cherkin D. C., Sherman K. J., Avins A. L. et al. A randomized trial comparing
acupuncture, simulated acupuncture, and usual care for chronic low back pain // Archives
of internal medicine. 2009. Vol. 169. № 9. P. 858–866.
Suarez-Almazor M. E., Looney C., Liu Y., Cox V., Pietz K. et al. A randomized
controlled trial of acupuncture for osteoarthritis of the knee: effects of patient-provider
communication // Arthritis care & research. 2010. September. Vol. 62. № 9. P. 1229–1236.
Dincer F., Linde K. Sham interventions in randomized clinical trials of acupuncture –
a review // Complementary Therapies in Medicine. 2003. December. Vol. 11. № 4. P. 235–
242.
Byard R. W., Musgrave I., Maker G., Bunce M. What risks do herbal products pose to
the Australian community? // The Medical journal of Australia. 2017. Vol. 206. № 2. P. 86–
90.
Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines // Trends
in Pharmacological Sciences. 2002. March 1. Vol. 23. № 3. P. 136–139.
Pittler M. H., Ernst E. Systematic review: hepatotoxic events associated with herbal
medicinal products // Alimentary pharmacology & therapeutics. 2003. Vol. 18. № 5. P. 451–
471.
Tanaka A., Nishida R., Yoshida T., Koshikawa M., Goto M., Kuwahara T. Outbreak of
Chinese herb nephropathy in Japan: are there any differences from Belgium? // Internal
medicine (Tokyo, Japan). 2001. April. Vol. 40. № 4. P. 296–300.
Zhang D., Yin P., Freemantle N., Jordan R., Zhong N., Cheng K. K. An assessment of
the quality of randomised controlled trials conducted in China // Trials. 2008. April. Vol. 9.
P. 22.
Gang Wang, Bing Mao, Ze-Yu Xiong, Tao Fan, Xiao-Dong Chen et al. The quality of
reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13
randomly selected journals from mainland China // Clinical Therapeutics. 2007. Vol. 29. №
7. P. 1456–1467.
Astin J. A. Why patients use alternative medicine: results of a national study // JAMA.
1998. Vol. 279. № 19. P. 1548–1553.
Култер К. P. Портреты гомеопатических препаратов. M.: Гомеопатическая
медицина, 2004.
Naidu K. A. Vitamin C in human health and disease is still a mystery? An overview //
Nutrition Journal. 2003. Vol. 2. P. 7.
Pauling L. Are recommended daily allowances for vitamin C adequate? // PNAS.
1974. November. Vol. 71. № 11. P. 4442–4446.
Offit P. The vitamin myth: Why we think we need supplements // The Atlantic. 2013.
July 19.
Anderson T. W. Reid D. B. W., Beaton G. H. Vitamin C and the common cold: a
double-blind trial // Canadian Medical Association Journal. 1972. Vol. 107. № 6. P. 503–
508.
Anderson T. W., Stiranyi G., Beaton G. H. The effect on winter illness of large doses of
vitamin C // Canadian Medical Association Journal. 1974. Vol. 111. P. 31–36.
Anderson T. W. Large-scale trials of vitamin C // Annals of the New York Academy of
Sciences. 1975. Vol. 258. P. 498–504.
https://t.me/medicina_free
Anderson T. W., Beaton G. H., Corey P., Spero L. Winter illness and vitamin C: the
effect of relatively low doses // Canadian Medical Association Journal. 1975. Vol. 112. № 7.
P. 823–826.
Cameron E., Pauling L. Supplemental ascorbate in the supportive treatment of cancer:
Prolongation of survival times in terminal human cancer // Proceedings of the National
Academy of Sciences of the United States of America. 1976. October. Vol. 73. № 10. P.
3685–3689.
Hemilä H., Chalker E. Vitamin C for preventing and treating the common cold //
Cochrane Database of Systematic Reviews. 2013. № 1. Art. № CD000980.
Iacopetta K., Collins-Praino L. E., Buisman-Pijlman F. T. A., Liu J. et al. Are the
protective benefits of vitamin D in neurodegenerative disease dependent on route of
administration? A systematic review // Nutritional Neuroscience. 2018. July. Vol. 9. P. 1–30.
Allan G. M., Cranston L., Lindblad A., McCormack J., Kolber M. R. et al. Vitamin D:
A narrative review examining the evidence for ten beliefs // Journal of General Internal
Medicine. 2016. July. Vol. 31. № 7. P. 780–791.
Bjelakovic G., Gluud L., Nikolova D., Whitfield K., Wetterslev J. et al. Vitamin D
supplementation for prevention of mortality in adults // Cochrane Database of Systematic
Reviews. 2014. № 1. Art. № CD007470.
Macpherson H., Pipingas A., Pase M. P. Multivitamin-multimineral supplementation
and mortality: a meta-analysis of randomized controlled trials // The American journal of
clinical nutrition. 2013. February. Vol. 97. № 2. P. 437–444.
The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The Effect of
Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male
Smokers // The New England Journal of Medicine. 1994. April 14. Vol. 330. P. 1029–1035.
Bjelakovic G., Nikolova D., Simonetti R. G., Gluud C. Antioxidant supplements for
preventing gastrointestinal cancers // Cochrane Database of Systematic Reviews. 2008.
July. Vol. 16. № 3, CD004183.
Omenn G. S., M. D., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R. et al.
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular
disease // The New England Journal of Medicine. 1996. May 2. Vol. 334. P. 1150–1155.
Miller E. R., Pastor-Barriuso R., Dalal D., Riemersma R. A., Appel L. J. et al. Meta-
analysis: high-dosage vitamin E supplementation may increase all-cause mortality //
Annals of Internal Medicine. 2005. Vol. 142. № 1. P. 37–46.
Dyerberg J. Coronary heart disease in Greenland Inuit: a paradox. Implications for
western diet patterns // Arctic medical research. 1989. April. Vol. 48. № 2. P. 47–54.
Abdelhamid A. S., Brown T. J., Brainard J. S., Biswas P., Thorpe G. C. et al. Omega-3
fatty acids for the primary and secondary prevention of cardiovascular disease // Cochrane
Database of Systematic Reviews. 2018. № 7. Art. № CD003177.
Kwak S. M., Myung S. K., Lee Y. J., Seo H. G. Efficacy of omega-3 fatty acid
supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary
prevention of cardiovascular disease: a meta-analysis of randomized, double-blind,
placebo-controlled trials // Archives of internal medicine. 2012. May 14. Vol. 172. № 9. P.
686–694.
Rizos E. C., Ntzani E. E., Bika E., Kostapanos M. S., Elisaf M. S. Association between
omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a
https://t.me/medicina_free
systematic review and meta-analysis // JAMA. 2012. September 12. Vol. 308. № 10. P.
1024–1033.
Aung T., Halsey J., Kromhout D. et al. Associations of Omega-3 fatty acid supplement
use with cardiovascular disease risks. Meta-analysis of 10 trials involving 77 917
individuals // JAMA Cardiology. 2018. Vol. 3. № 3. P. 225–233.
Bhatt D. L., Steg P. G., Miller M., Brinton E. A., Jacobson T. A. et al. Cardiovascular
risk reduction with icosapent ethyl for hypertriglyceridemia // The New England Journal of
Medicine. 2019. January 3. Vol. 380. P. 11–22.
Manson J. E., Cook N. R., I – Min Lee, Christen W., Bassuk S. S. et al. Marine n-3
fatty acids and prevention of cardiovascular disease and cancer // The New England
Journal of Medicine. 2019. January 3. Vol. 380. P. 23–32.
Carroll A. E. Given Their Potential for Harm, It’s Time to Focus on the Safety of
Supplements // JAMA. 2018. Vol. 320. № 13. P. 1306–1307.
Newmaster S. G., Grguric M., Shanmughanandhan D., Ramalingam S., Ragupathy S.
DNA barcoding detects contamination and substitution in North American herbal products
// BMC medicine. 2013. Vol. 11. № 1. P. 222.
Harmon K. Herbal supplement sellers dispense dangerous advice, false claims //
Scientific American. 2010. May 28.
Geller A. I., Shehab N., Weidle N. J., Lovegrove M. C., Wolpert B. J. et al. Emergency
department visits for adverse events related to dietary supplements // The New England
Journal of Medicine. 2015. October 15. Vol. 373. P. 1531–1540.
Gregory P. Availability of DMAA supplements despite US food and drug
administration action // JAMA Internal Medicine. 2013. Vol. 173. № 2. P. 164–165.
Zhang Y., Woods R. M., Breitbach Z. S., Armstrong D. W. 1,3-Dimethylamylamine
(DMAA) in supplements and geranium products: natural or synthetic? // Drug Testing and
Analysis. 2012. Vol. 4. P. 986–990.
Lindeboom G. A. The story of a blood transfusion to a pope // Journal of the History
of Medicine and Allied Sciences. 1954. October 1. Vol. 9. № 4. P. 455–459.
Kaiser J. Blood from young people does little to reverse Alzheimer’s in first test //
Science. 2017. November 1.
Cooper D. K. C. A brief history of cross-species organ transplantation // Proceedings
(Baylor University. Medical Center). 2012. January. Vol. 25. № 1. P. 49–57.
Bajic P., Selman S. H., Rees M. A. Voronoff to virion: 1920s testis transplantation and
AIDS // Xenotransplantation. 2012. November-December. Vol. 19. № 6. P. 337–341.
Setchell B. P. The testis and tissue transplantation: historical aspects // Journal of
reproductive immunology. 1990. August. Vol. 18. № 1. P. 1–8.
Wang H., Zhao Y., Ezcurra M., Benedetto A., Gilliat A. F., Hellberg J., Ren Z. et al. A
parthenogenetic quasi-program causes teratoma-like tumors during aging in wild-type C.
elegans // npj Aging and Mechanisms of Disease. 2018. Vol. 4. Art. № 6.
Cheetham T. C., An J., Jacobsen S. J. et al. Association of testosterone replacement
with cardiovascular outcomes among men with androgen deficiency // JAMA Internal
Medicine. 2017. Vol. 177. № 4. P. 491–499.
Basaria S., Coviello A. D. Travison T. G., Storer T. W., Farwell W. R. et al. Adverse
events associated with testosterone administration // The New England Journal of
Medicine. 2010. July 8. Vol. 363. № 2. P. 109–122.
https://t.me/medicina_free
Bhasin S., Cunningham G. R., Hayes F. J., Matsumoto A. M., Snyder P. J. et al.
Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine
Society clinical practice guideline // The Journal of Clinical Endocrinology & Metabolism.
2006. June 1. Vol. 91. № 6. P. 1995–2010.
Rudman D., Feller A. G., Nograj H. S., et al. Effects of human growth hormone in men
over 60 years old // The New England Journal of Medicine. 1990. Vol. 323. № 1. P. 1–6.
Swerdlow A. J., Cooke R., Beckers D., Borgström B., Butler G. et al. Cancer risks in
patients treated with growth hormone in childhood: the SAGhE European cohort study //
The Journal of clinical endocrinology and metabolism. 2017. May 1. Vol. 102. № 5. P.
1661–1672.
Robida-Stubbs S., Glover-Cutter K., Lamming D. W., Mizunuma M. et al. TOR
signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO //
Cell metabolism. 2012. May 2. Vol. 15. № 5. P. 713–724.
Bhullar K. S., Hubbard B. P. Lifespan and healthspan extension by resveratrol //
Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease. 2015. June. Vol. 1852.
№ 6. P. 1209–1218.
Rousakis A., Vlassis A., Vlanti A., Patera S., Thireos G., Syntichaki P. The general
control nonderepressible-2 kinase mediates stress response and longevity induced by target
of rapamycin inactivation in Caenorhabditis elegans // Aging Cell. 2013. Vol. 12. № 5. P.
742–751.
Baur J. A., Pearson K. J., Price N. L., Jamieson H. A., Lerin C., Kalra A. et al.
Resveratrol improves health and survival of mice on a high-calorie diet // Nature. 2006.
November 16. Vol. 444. № 7117. P. 337–342.
Pearson K. J., Baur J. A., Lewis K. N., Peshkin L., Price N. L., Labinskyy N. et al.
Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary
restriction without extending life span // Cell metabolism. 2008. August. Vol. 8. № 2. P.
157–168.
Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the
conundrum of the ‘French paradox’? // European Journal of Endocrinology. 1998. June.
Vol. 138. № 6. P. 619–620.
Goldberg D. M., Yan J., Soleas G. J. Absorption of three wine-related polyphenols in
three different matrices by healthy subjects // Clinical biochemistry. 2003. February. Vol.
36. № 1. P. 79–87.
Law M., Wald N. Why heart disease mortality is low in France: the time lag
explanation // BMJ. 1999. May 29. Vol. 318. № 7196. P. 1471–1480.
Vang O. What is new for resveratrol? Is a new set of recommendations necessary? //
Annals of the New York Academy of Sciences. 2013. July. Vol. 1290. № 1. P. 1–11.
Vaziri H., Dragowska W., Allsopp R. C., Thomas T. E., Harley C. B., Lansdorp P. M.
Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with
age // PNAS. 1994. October 11. Vol. 91. № 21. P. 9857–9860.
Jodczyk S., Fergusson D. M., Horwood L. J., Pearson J. F., Kennedy M. A. No
association between mean telomere length and life stress observed in a 30 year birth cohort
// PLoS One. 2014. Vol. 9. № 5, e97102.
Chae D. H., Nuru-Jeter A. M., Adler N. E., Brody G. H., Lin J., Blackburn E. H., Epel
E. S. Discrimination, racial bias, and telomere length in African-American men //
https://t.me/medicina_free
American journal of preventive medicine. 2014. February. Vol. 46. № 2. P. 103–111.
Jaskelioff M., Muller F. L., Paik J.-H., Thomas E., Jiang S., Adams A. et al.
Telomerase reactivation reverses tissue degeneration in aged telomerase deficient mice //
Nature. 2011. January 6. Vol. 469. № 7328. P. 102–106.
Sprouse A. A., Steding C. E., Herbert B.-S. Pharmaceutical regulation of telomerase
and its clinical potential // Journal of cellular and molecular medicine. 2012. January. Vol.
16. № 1. P. 1–7.
Sanders J. L., Newman A. B. Telomere length in epidemiology: a biomarker of aging,
age-related disease, both, or neither? // Epidemiologic Reviews. 2013. January 1. Vol. 35.
№ 1. P. 112–131.
notes
https://t.me/medicina_free
Соседние файлы в папке Библиотека им академика М.И. Перельмана